<DOC>
	<DOCNO>NCT02718131</DOCNO>
	<brief_summary>The current study propose add BMP-2 ( INFUSE ) , anabolic agent , surgical site TPA repair child NF1 , compare control group patient treat surgically without BMP-2 . The follow Specific Aims address : 1 ) determine use osteogenic agent ( BMP-2 ) time surgical repair TPA NF1 patient result improve bone healing ; 2 ) document safety BMP-2 pediatric NF1 population ; 3 ) collect , process , preserve biologic specimen time surgery future study .</brief_summary>
	<brief_title>A Study INFUSE Bone Graft ( BMP-2 ) Treatment Tibial Pseudarthrosis Neurofibromatosis Type 1 ( NF1 )</brief_title>
	<detailed_description>A randomize study perform multi-center group NF Consortium . A total 54 patient randomize treatment without INFUSE Bone Graft time surgical repair . For patient , standard surgical procedure use , include : resection pseudarthrosis tissue ; placement rigid intramedullary rod ; placement autogenous bone graft iliac crest . For patient BMP group , INFUSE device contain BMP-2 addition apply intraoperatively osteotomy site . Fracture union determine score radiograph ( RUST score ) cortical bone fusion callus formation osteotomy site . RUST score 12 month post-surgery primary outcome measure determine efficacy . Secondary measure include determination time heal ( month ) ; quality life measure ; functional walking measure ; incidence refracture surgery . This study , successfully complete , determine use INFUSE Bone Graft improve heal tibial pseudarthrosis NF1 document safety issue . Regardless result , good perform two group ( control BMP ) able serve much-needed control arm future study additional target therapeutic agent NF1-related bone disease . An international working group orthopaedic surgeon NF specialist form committed successful completion trial .</detailed_description>
	<mesh_term>Neurofibromatoses</mesh_term>
	<mesh_term>Neurofibroma</mesh_term>
	<mesh_term>Pseudarthrosis</mesh_term>
	<mesh_term>Neurofibromatosis 1</mesh_term>
	<criteria>Diagnosis NF1 use NIH Consensus Conference criterion . In addition tibial pseudarthrosis , one follow diagnostic criterion NF1 must present : Six cafe'aulait spot ( ≥ 0.5cm prepubertal ; ≥ 1.5cm postpubertal ) Freckling axilla groin Optic pathway glioma Two iris Lisch nodule Two neurofibromas one plexiform neurofibroma A firstdegree relative NF1 Patients must tibial pseudarthrosis potential cause significant morbidity . Radiographic finding ( AP &amp; lateral leg radiograph ) must support diagnosis tibial pseudarthrosis chronic nonunion . Age 2 year 18 year age time study entry . Performance Level : Karnofsky ≥ 50 percent patient &gt; 10 year age Lansky ≥ 50 percent patient ≤ 10 year age . Prior Therapy : Patients undergo 1 previous surgery tibial pseudarthrosis repair eligible enter study refracture . Use BMP2 prior surgery permit , however patient prior exposure must screen antibody BMP2 , bovine collagen , rhBMP2 neutralize antibody . Prior use BMP2 allow record possible compounding factor . Patients 2 prior surgery pseudarthrosis repair ineligible Absence Tumors : Patients must undergo thorough physical examination leg undergoing surgery . If physical exam equivocal presence tumor , normal MRI low extremity require eligibility meet . If evidence plexiform neurofibroma nodular neurofibroma &gt; 3 cm diameter ipsilateral leg , ineligible study . Organ Function Requirements Adequate bone marrow function define : Absolute neutrophil count ( ANC ) &gt; 1500/ µl Platelet count &gt; 100,000/ µl Hemoglobin ≥ 10.0 gm/dL Adequate renal function define : maximum serum creatinine 1.5 mg/dL OR creatinine clearance≥70ml/min/1.73m2 . Adequate renal function define : maximum serum creatinine 1.5 mg/dL OR creatinine clearance ≥ 70ml/min/1.73m2 . Adequate liver function define : Total bilirubin &lt; 1.5 X upper limit normal age , SGPT ( ALT ) &lt; 2 X upper limit normal age Serum Vitamin D level ≥ 10 ng/ml Lack documentation diagnosis NF1 Tibial fracture without evidence pseudarthrosis tibial dysplasia Tibial dysplasia/bowing without fracture pseudarthrosis Plexiform neurofibroma size , nodular neurofibroma &gt; 3 cm diameter involve ipsilateral leg , include hip If presence plexiform suspect certain physical exam , MRI leg may indicate rule . History MPNST ( malignant peripheral nerve sheath tumor ) malignancy asymptomatic stable optic nerve glioma Optic nerve glioma result precocious puberty visual impairment degree Visual impairment cause Precocious puberty cause Hypertension mild essential hypertension control medication Metastatic disease kind Inadequate neurovascular status involve limb may jeopardize heal Active know prior infection pseudarthrosis site Active systemic infection Other injury condition prevents ambulation completion study assessment Two prior surgery tibial pseudarthrosis Bilateral tibial dysplasia Selection surgical approach include prescribed surgical intervention , must include removal pseudarthrosis tissue , placement intramedullary rod use Williams approach , autogenous bone graft iliac crest distribute osteotomy site Normal ipsilateral fibula without plan fibular osteotomy time surgery Allergy bone morphogenetic protein Allergy bovine collagen product Positive antibody titer BMP2 , bovine collagen , BMP2 neutralize antibody prior surgery History use follow medication , regardless dose , least 1 month , within 3 month enrollment : Anabolic agent , Glucocorticoids ( include inhale glucocorticoid ) , Growth hormone , Parathyroid hormone ( PTH ) Need postoperative medication could interfere bone heal implant , steroid , ( include lowdose aspirin routine perioperative antiinflammatory drug ) Untreated endocrine abnormality , hypothyroidism , parathyroid hormone disorder Severe Vitamin D deficiency serum 25OH Vitamin D &lt; 10 ng/ml ( 25 nmol/l ) Patients Vitamin D level &lt; 10 ng/ml may treat Vitamin D reconsider enrollment level sufficient Females sexually active without use effective contraception Females pregnant breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Tibial Pseudarthrosis</keyword>
</DOC>